One French adult in three complains of insomnia and 21.5% sleep six hours or less. Sleep has become, with stress, the second engine of the food supplement market. It is also the most regulated segment: melatonin dose, authorised botanicals, populations to protect, claims. Here is how to build a solid sleep formula, from the Irati Production R&D team.
Contact us
The 2024 Santé publique France barometer measures an average sleep time of 7 h 32 per 24 hours among 18 to 79-year-olds, 21.5% short sleepers at six hours or less, and an insomnia complaint in about one adult in three, up to 43% among women aged 70 to 79. On the market side, the 2026 Synadiet barometer ranks tiredness, poor sleep and stress among the first reasons to take a supplement, cited by 41 to 45% of consumers; among 18 to 34-year-olds, 59% say their sleep is often a problem.
For a brand, sleep is therefore a repeat-purchase category with a wide audience and a high basket. It is also the category where authorities look most closely at labels.

The Ferracioli-Oda meta-analysis (2013, 19 trials, 1,683 participants) measures melatonin's effect: sleep onset 7 minutes earlier on average, total sleep time 8 minutes longer and improved perceived quality. A real, modest, well-documented effect. Our PubMed count ranks melatonin 7th among the most studied ingredients, with 1,628 human clinical trials.
In France, a food supplement may provide less than 2 mg of melatonin a day; at 2 mg it is a medicine. The authorised claim is a single one: "melatonin contributes to the reduction of time taken to fall asleep", for 1 mg per serving, with the information that the effect is obtained by taking 1 mg before bedtime. A second claim exists on jet lag, from 0.5 mg. The 2018 ANSES opinion, based on 90 nutrivigilance reports, recommends avoiding melatonin in pregnant or breastfeeding women, children and adolescents, people with inflammatory or autoimmune diseases and those who must remain alert, and advises medical advice in case of epilepsy, asthma or drug treatment. These precautions appear on the labels of the formulas we manufacture.
The French order of 24 June 2014 lists the plants authorised in food supplements and, for some, the substances to monitor:
Glycine at 3 g at bedtime improved sleep quality and reduced morning fatigue in the Yamadera (2007) and Inagawa (2006) trials. L-theanine at 200 mg a day improved the PSQI sleep score in a 2019 crossover trial. GABA and 5-HTP are sold in France without status in the 2016 order; tryptophan is generally dosed at 220 mg. None of these substances has an authorised claim: EFSA rejected those of L-theanine and 5-HTP. They bring a formulation argument, not a label argument.
A sleep formula that holds up therefore rests on two label pillars, magnesium and vitamin B6, which contribute to a reduction of tiredness and fatigue, to normal functioning of the nervous system and to normal psychological function, and on melatonin at 1 mg for sleep onset. Botanicals and amino acids enrich the formula and the editorial story.
It is taken in the evening, often without water at hand:
You can start from one of our standard formulas (melatonin and magnesium, night electrolytes in stick packs) or have a custom formula developed. Our regulatory team checks the melatonin dose, the botanicals and their monitored substances, the populations to mention and every claim before the first label.

Irati Production manufactures sleep formulas as capsules, tablets, pectin-based gummies and stick pack powders in its Saumur unit, ISO 22000 certified, HACCP approach and FDA-registered.
Less than 2 mg a day. At 2 mg, melatonin is a medicine. The claim "contributes to the reduction of time taken to fall asleep" is authorised for 1 mg per serving, taken before bedtime. Irati Production manufactures its sleep formulas within this frame.
For melatonin, the reduction of time taken to fall asleep (1 mg) and the alleviation of jet lag (0.5 mg). For magnesium and vitamin B6, the reduction of tiredness and fatigue, normal functioning of the nervous system and normal psychological function. Botanicals, glycine, L-theanine and GABA have no authorised claim.
According to the 2018 ANSES opinion: pregnant or breastfeeding women, children and adolescents, people with inflammatory or autoimmune diseases, people who must remain alert; medical advice in case of epilepsy, asthma, mood disorders or drug treatment. These statements appear on the labels of formulas made by Irati Production.
The plants of the French order of 24 June 2014: valerian, passionflower, lemon balm, California poppy, hops, lime blossom, chamomile, lavender, hawthorn, with documentation of monitored substances. Ashwagandha can be used with the ANSES precautions.
The Ferracioli-Oda meta-analysis (2013) measures sleep onset 7 minutes earlier and total sleep 8 minutes longer on average, with improved perceived quality. A real, modest effect, documented by 1,628 human clinical trials in PubMed.
Irati Production manufactures private label sleep formulas in its Saumur unit, as capsules, tablets, pectin-based gummies and stick pack powders, on standard or custom formulas.
The information in this article is general and does not constitute regulatory advice. Each formula undergoes a technical and regulatory feasibility study.
Melatonin, magnesium, botanicals: let's talk about your formula.
Contact us